Skip to main content
letter
. 2022 Jun 9;85(3):334–363. doi: 10.1016/j.jinf.2022.06.004

Table 1a.

Patient demographics and baseline characteristics in Qinghai cohort.

All Cases(N = 10) Mild(N = 2) Moderate(N = 4) Severe(N = 4)
Gender, n (%)
 Male 1 (10%) 0 (0%) 0 (0%) 1 (25%)
 Female 9 (90%) 2 (100%) 4 (100%) 3 (75%)
Age (years)
 Mean ± SD 41.9 ± 16.64 31.5 ± 0.5 31 ± 2.55 58 ± 15.92
 Median 33 31.5 31.5 58.5
 Min: Max 27:80 31:32 27:34 35:80
Age group, n (%)
 ≤ 65 years 9 (90%) 2 (100%) 4 (100%) 3 (75%)
 > 65 years 1 (10%) 0 (0%) 0 (0%) 1 (25%)
Vaccination to disease onset (days)
 Mean ± SD 194.78 ± 88.54 245 ± 57 240 ± 77.62 101 ± 10.71
 Median 170.5 245 278.5 99
 Min: Max 89:302 188:302 107:296 89:115
Symptom onset to treatment (days)
 Mean ± SD 5.8 ± 3.31 3.5 ± 1.5 3.75 ± 1.79 9 ± 2.45
 Median 5 3.5 3.5 10
 Min: Max 2:11 2:5 2:6 5:11

*The most severe stage experienced by patient was used as the diagnostic type (mild, moderate, severe).